Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691574 · ClinicalTrials.gov registry record · NA
Melatonin Levels in Smith Magenis Syndrome (SMS)
A NA study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00691574 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 5 participants.
The verdict
NCT00691574, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal of this pilot project is to determine whether melatonin levels are disordered in patients with Smith-Magenis Syndrome (SMS) and whether melatonin treatment can correct abnormal circadian rhythms in SMS patients. In addition, the study investigates the effects of bright light in an elderly control population that exhibits low melatonin secretion.
Interventions
- DIETARY_SUPPLEMENT Melatonin
- DEVICE Enviro-light artificial light box
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 1998-09 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00691574
The ClinicalTrials.gov registry entry for NCT00691574 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Melatonin is the first listed.
NCT00691574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00691574 about?
NCT00691574 is a clinical study titled "Melatonin Levels in Smith Magenis Syndrome (SMS)". The goal of this pilot project is to determine whether melatonin levels are disordered in patients with Smith-Magenis Syndrome (SMS) and whether melatonin treatment can correct abnormal circadian rhythms in SMS patients. In addition, the study investigates the effects of bright light in an elderly c...
What is the current status of trial NCT00691574?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 1998-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00691574?
The interventions under investigation include: Melatonin (DIETARY_SUPPLEMENT), Enviro-light artificial light box (DEVICE).
Who is sponsoring clinical trial NCT00691574?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.